✦ LIBER ✦

A randomized trial of IFNα and IL-2 ± cisplatinum in advanced melanoma — a preliminary analysis

✍ Scribed by U Keilholz; Heidelberg; A.M.M. Eggermont

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized trial of IFNα/IL-2 with or

✍ Keilholz, U.; Goey, S.H.; Punt, C.J.A.; Scheibenbogen, C.; Proebstle, T.; Salzma 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 263 KB

Combination chemotherapy with or without

✍ Atzpodien, J; Neuber, K; Kamanabrou, D; Fluck, M; Bröcker, E B; Neumann, C; Rüng 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 92 KB

SC IL-2 and IFN-α-2a + IV cisplatin for

📂 Article 📅 1998 🏛 Adis International Limited (now part of Wolters Kl ⚖ 243 KB

A phase 2 trial of dasatinib in advanced

✍ Harriet M. Kluger; Arkadiuz Z. Dudek; Carrie McCann; Jean Ritacco; Nadine Southa 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB

214 Fotemustine, dacarbazine (DTIC) and

✍ P. Comella; F. Presutti; A. Daponte; R. Casaretti; G. Frasci; G. Palmieri; R. Ga 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 155 KB

Prognostic factors for survival and fact

✍ U. Keilholz; P. Martus; C.J.A. Punt; W. Kruit; G. Mooser; D. Schadendorf; D. Lié 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 166 KB